搜尋
Nervgen Pharma Ord Shs
NGEN添加自選
4.070USD
-0.090-2.16%
收盤 04/17, 16:00（美東）報價延遲15分鐘
324.17M總市值
虧損本益比TTM
關於 Nervgen Pharma Ord Shs 公司
NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in developing treatments to promote nervous system repair in the settings of neurotrauma and neurologic disease. NVG-291 is in a Phase 1b/2a clinical trial in spinal cord injury and has undertaken preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI). Its NVG-291 is a therapeutic peptide targeting nervous system repair.
Nervgen Pharma Ord Shs簡介
公司代碼NGEN
公司名稱NervGen Pharma Corp
上市日期Mar 13, 2019
CEORogers (Adam H)
員工數量- -
證券類型Ordinary Share
年結日- -
公司地址Suite 1703 - 595 Burrard Street
城市VANCOUVER
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Canada
郵編V7X 1J1
電話16047225361
網址https://www.nervgen.com/
公司代碼NGEN
上市日期Mar 13, 2019
CEORogers (Adam H)
Nervgen Pharma Ord Shs公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Randall E. Kaye, M.D.
Dr. Randall E. Kaye, M.D.
Independent Director
Independent Director
160.00K
--
Ms. Krista L. Mckerracher
Ms. Krista L. Mckerracher
Independent Director
Independent Director
27.76K
-54.04%
Mr. William J. (Bill) Adams
Mr. William J. (Bill) Adams
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
--
--
Dr. Daniel D. (Dan) Mikol, M.D., Ph.D
Dr. Daniel D. (Dan) Mikol, M.D., Ph.D
Chief Medical Officer
Chief Medical Officer
--
--
Mr. John Craig Thompson
Mr. John Craig Thompson
Independent Director
Independent Director
--
--
Dr. Adam H. Rogers
Dr. Adam H. Rogers
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. Gianni (John) Ruffolo
Mr. Gianni (John) Ruffolo
Independent Director
Independent Director
--
--
Mr. Neil A. Klompas, CPA
Mr. Neil A. Klompas, CPA
Independent Director
Independent Director
--
--
Mr. Huitt Tracey
Mr. Huitt Tracey
Investor Relations
Investor Relations
--
--
,
,
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Randall E. Kaye, M.D.
Dr. Randall E. Kaye, M.D.
Independent Director
Independent Director
160.00K
--
Ms. Krista L. Mckerracher
Ms. Krista L. Mckerracher
Independent Director
Independent Director
27.76K
-54.04%
Mr. William J. (Bill) Adams
Mr. William J. (Bill) Adams
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
--
--
Dr. Daniel D. (Dan) Mikol, M.D., Ph.D
Dr. Daniel D. (Dan) Mikol, M.D., Ph.D
Chief Medical Officer
Chief Medical Officer
--
--
Mr. John Craig Thompson
Mr. John Craig Thompson
Independent Director
Independent Director
--
--
Dr. Adam H. Rogers
Dr. Adam H. Rogers
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
收入明細
由於公司未披露，未能獲取相關數據
由於公司未披露，未能獲取相關數據
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 1月9日 週五
更新時間: 1月9日 週五
持股股東
股東類型
持股股東
持股股東
佔比
PFP Biosciences Holdings LLC
18.24%
Punnett, Harold
1.46%
Bayley (Brian E)
0.70%
Kaye (Randall E)
0.20%
Ruffolo (John)
0.09%
其他
79.31%
持股股東
持股股東
佔比
PFP Biosciences Holdings LLC
18.24%
Punnett, Harold
1.46%
Bayley (Brian E)
0.70%
Kaye (Randall E)
0.20%
Ruffolo (John)
0.09%
其他
79.31%
股東類型
持股股東
佔比
Other Insider Investor
18.24%
Individual Investor
2.51%
其他
79.25%
機構持股
更新時間: 1月9日 週五
更新時間: 1月9日 週五
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
2
--
0.00%
-47.80K
2025Q4
2
--
0.00%
-47.80K
2025Q3
2
--
0.00%
-47.80K
2025Q2
2
--
0.00%
-47.80K
2025Q1
2
--
0.00%
-47.80K
2024Q4
2
--
0.00%
-47.80K
2024Q3
2
--
0.00%
-47.80K
2024Q2
3
44.40K
0.06%
-41.20K
2024Q1
2
3.40K
0.01%
-30.00K
2023Q4
2
3.40K
0.01%
-30.00K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
PFP Biosciences Holdings LLC
14.69M
18.24%
+1.81M
+14.05%
Nov 19, 2025
Punnett, Harold
1.18M
1.46%
+50.00K
+4.44%
Jul 18, 2025
Bayley (Brian E)
565.00K
0.7%
+250.00K
+79.37%
Nov 19, 2025
Kaye (Randall E)
160.00K
0.2%
+50.00K
+45.45%
Jan 04, 2026
Ruffolo (John)
70.41K
0.09%
--
--
Mar 28, 2025
Mckerracher (Krista L)
49.76K
0.06%
-10.00K
-16.73%
Mar 02, 2026
Rogers (Adam)
20.00K
0.02%
+10.00K
+100.00%
May 16, 2025
Mikol (Daniel D. M.D., Ph.D)
5.00K
0.01%
+5.00K
--
May 20, 2025
Timelo Investment Management Inc.
--
0%
-44.40K
-100.00%
Aug 31, 2024
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
